Finance ❯ Investments

Mergers and Acquisitions

Corporate Strategy Public Companies Market Trends Pharmaceutical Industry Valuation Fintech Corporate Finance Power Solutions Acquisition Unicredit and Commerzbank Google Reverse Listings Performance-Based Payments Special Purpose Acquisition Companies Market Share Deal Structure Shareholder Value Crypto Companies Airline Industry Stock Transactions Electronic Arts WarnerMedia Acquisition Biotech Sector Biopharma Valuation Biotech Companies Asset Sale Morgan Stanley Stake Purchases TikTok Deal Takeover Bids Corporate Valuation Market Analysis Market Opportunities Institutional Investors International Investments OnlyFans Sale Venture Capital Novartis

Dycom Posts Record Quarter and Year, Sets 2027 Outlook With Backlog at All-Time High

Guidance leans on a record backlog, with BEAD awards expected to begin converting soon as the company plans to lower leverage.

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Exodus to Acquire Uruguay’s Grateful to Expand Stablecoin Payments for Latin American Merchants

Longleaf Partners’ Q3 Letter: Fund Lags Benchmarks as Buybacks Drive Value Plan

NYDIG Urges Bitcoin Treasury Firms to Scrap mNAV After Strive–Semler Deal

Pfizer to Buy Metsera in Up to $7.3 Billion Obesity Bet

AbbVie Agrees to Buy Gilgamesh’s Bretisilocin for Up to $1.2 Billion

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy